Navegar por "Hematoloxía"

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

2023- Mosquera Orgueira, Adrián; Díaz Arias, José; Serrano Martín, R.; Portela Piñeiro, V.; Cid López, Miguel; [et al.]

AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib

2023- Duminuco, A.; Mosquera Orgueira, Adrián; Nardo, A.; Di Raimondo, F.; Palumbo, G.A. [et al.]

Application of IPSET-Thrombosis in 1366 Patients Prospectively Followed from the Spanish Registry of Essential Thrombocythemia

2023- Alvarez-Larrán, A.; Cuevas, B.; Velez, P.; Noya Pereira, María Soledad; Caballero-Navarro, G.; [et al.]

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program

2023- Laws, H.-J.; Fukutake, K.; López Fernández, María Fernanda; Li, Y.; Seifert, W.; [et al.]

Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

2023- Bernal, T.; Moreno, A.F.; de LaIglesia, A.; Benavente, C.; García-Noblejas, A.; [et al.]

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

2023- Sargas, C.; Ayala, R.; Larráyoz, M.J.; Chillón, M.C.; Rodriguez-Arboli, E.; [et al.]

Expert opinion paper on the treatment of hemophilia a with emicizumab

2023- López-Jaime, F.-J.; Benítez, O.; Díaz Jordán, B.L.; Montaño, A.; Coll, J.; [et al.]

Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

2023- de la Rubia, J.; González, B.; Cruz-Jentoft, A.J.; García Iglesias, Lorena; Jarque, I.; [et al.]

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

2023- Chumbita, M.; Puerta-Alcalde, P.; Yáñez, L.; Angeles Cuesta, M.; Chinea, A.; [et al.]

IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

2023- Vallejo Llamas, Juan Carlos; Jarque, I.; Fortun, J.; Casado, A.; Peman, J. [et al.]

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

2023- Ruggeri, A.; de Wreede, L.C.; Müller, C.R.; Crivello, P.; Bonneville, E.F.; [et al.]

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

2023- Mosquera Orgueira, Adrián; Pérez Encinas, Manuel Mateo; Diaz Varela, N.A.; Mora, E.; Díaz-Beyá, M.; [et al.]

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

2023- Mosquera Orgueira, Adrián; Pérez Encinas, Manuel Mateo; Hernández-Sánchez, A.; González Martínez, María Teresa; Arellano-Rodrigo, E.; [et al.]

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

2023- Sargas, C.; Ayala, R.; Larráyoz, M.J.; Chillón, M.C.; Carrillo-Cruz, E.; [et al.]

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

2023- Salmanton-García, J.; Marchesi, F.; Koehler, P.; Weinbergerová, B.; ?olovi?, N.; [et al.]

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

2023- Marchesi, F.; Salmanton-García, J.; Buquicchio, C.; Itri, F.; Besson, C.; [et al.]

Repositorio digital RUNA

Navegar por "Hematoloxía"

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma ﻿

AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib ﻿

Application of IPSET-Thrombosis in 1366 Patients Prospectively Followed from the Spanish Registry of Essential Thrombocythemia ﻿

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program ﻿

Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry ﻿

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group ﻿

Expert opinion paper on the treatment of hemophilia a with emicizumab ﻿

Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study ﻿

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations ﻿

IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients ﻿

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation ﻿

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes ﻿

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis ﻿

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry ﻿

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry ﻿

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry ﻿

A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma

AIPSS-MF machine learning prognostic score validation in a cohort of myelofibrosis patients treated with ruxolitinib

Application of IPSET-Thrombosis in 1366 Patients Prospectively Followed from the Spanish Registry of Essential Thrombocythemia

Assessment of joint bleeding and target joints in patients with severe or moderately severe hemophilia B (factor IX ?2%) receiving prophylaxis with rIX-FP in the PROLONG-9FP clinical trial program

Clinical outcomes after CPX-351 in patients with high-risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

Expert opinion paper on the treatment of hemophilia a with emicizumab

Geriatric assessment in hematology scale predicts treatment tolerability in older patients diagnosed with hematological malignancies: The RETROGAH study

High Rate of Inappropriate Antibiotics in Patients with Hematologic Malignancies and Pseudomonas aeruginosa Bacteremia following International Guideline Recommendations

IFISTRATEGY: Spanish National Survey of Invasive Fungal Infection in Hemato-Oncologic Patients

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation

Machine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes

Machine Learning Improves Risk Stratification in Myelofibrosis: An Analysis of the Spanish Registry of Myelofibrosis

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry